PMC:7536954 / 3936-4147
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T51 | 12-20 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T52 | 133-135 | Disease | denotes | HS | http://purl.obolibrary.org/obo/MONDO_0006559 |
| T53 | 139-142 | Disease | denotes | SLE | http://purl.obolibrary.org/obo/MONDO_0007915 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T25 | 181-187 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T26 | 199-204 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T33 | 96-98 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T35 | 133-135 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056 |
| T36 | 199-204 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 163 | 96-102 | Gene | denotes | IL‐17A | Gene:3605 |
| 171 | 152-163 | Chemical | denotes | Secukinumab | MESH:C555450 |
| 177 | 12-20 | Disease | denotes | COVID‐19 | MESH:C000657245 |
| 178 | 139-142 | Disease | denotes | SLE | MESH:D008180 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T40 | 133-135 | Phenotype | denotes | HS | http://purl.obolibrary.org/obo/HP_0040154 |
| T41 | 139-142 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T37 | 31-143 | Sentence | denotes | Previous publications reported clinical improvements obtained by IL‐17A inhibition in treating either HS or SLE. |